首页> 外文期刊>Advances in Breast Cancer Research >Clinical Experience and Dosimetry Outcome in Treating Breast Cancer with Field-in-Field Technique
【24h】

Clinical Experience and Dosimetry Outcome in Treating Breast Cancer with Field-in-Field Technique

机译:用现场技术治疗乳腺癌的临床经验和剂量计量结果

获取原文
       

摘要

Purpose: The study is aimed to establish the dosimetric characteristics of field-in-field (FiF) technique for carcinoma of breast treatment in Nepal. We assumed that FIF technique may result in improved dose distribution and reduced acute toxicity in these patients. Methods: Forty breast cancer patient s participated in this study. A total dose of 50 Gy in 25 fractions was prescribed to the planning target volume. FiF plan was generated in treatment planning system. Dose volume histograms w ere evaluated for PTV and organs at risks. Several parameters were analyzed for the PTVs and organ at risks (OARs) together with the Conformity index (CI), and the Homogeneity index (HI). Results: The dose coverage of breast volume was achieved. The V _( 95% ) (volume of 95%) of PTV covered D _( 95% ) (Dose of 95%). The PTV dose was covered to 49.98 ± 0.9 Gy and 49.81 ± 1.1 Gy for the left and right breast, respectively. The mean lung dose was 14.87 ± 0.91 Gy. The homogeneity index (0.26 ± 0.17 and 0.22 ± 0.13) and conformity index (1.59 ± 0.75 and 1.36 ± 0.45) were analyzed for left and right breast, respectively. Conclusion: The study supports the viability of FiF technique in the treatment of breast cancer in Nepal. The FIF technique enables better dose distribution in the PTV and reduces dose to OARs. The FiF technique provides dosimetric advantages and requires less planning time.
机译:目的:该研究旨在建立尼泊尔乳房治疗癌癌野外局部(FIF)技术的剂量分析。我们假设五种技术可能导致这些患者的剂量分布和减少急性毒性。 方法:40例乳腺癌患者参加了这项研究。规划目标体积规定了25分级分中的总剂量为50μm。五项计划是在治疗计划系统中产生的。剂量体积直方图WERE评估了PTV和器官的风险。在风险(OAR)以及统一指数(CI)以及均匀性指数(HI)的情况下分析了几种参数。 结果:实现了乳房量的剂量覆盖。 PTV的V _(95%)(95%的体积)PTV覆盖D _(95%)(剂量为95%)。 PTV剂量分别覆盖左右乳房49.98±0.9 gy和49.81±1.1 gy。平均肺剂量为14.87±0.91gy。分别对左右乳房分析均匀性指数(0.26±0.17和0.22±0.22±0.22±0.22±0.22±0.45)。 结论:该研究支持FIT技术在尼泊尔治疗乳腺癌中的可行性。 FIF技术能够在PTV中更好地分布,并将剂量减少到桨。 FIF技术提供了多迭代优势,需要更少的规划时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号